Open AccessSafety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
Author(s) -
Cuiyun Li,
Min Wu,
Hong Zhang,
Jiajia Mai,
Lizhi Yang,
Yanhua Ding,
Junqi Niu,
John Mao,
Wenqiang Wu,
Dong Zhang,
Yanan Tang,
Wenhao Yan
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01220-21
Subject(s) - tolerability , pharmacokinetics , medicine , cmax , placebo , adverse effect , pharmacology , hepatitis b virus , gastroenterology , hepatitis b , virus , virology , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom